betking casino
swerte gaming Popular Arthritis Drug for Dogs May Have Severe Side Effects, F.D.A. Says
A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by the U.S. Food and Drug Administration, which approved the drug last year. In some cases, dogs have died or have been euthanized after developing these symptomsswerte gaming, the agency noted.
The drug, called Librela, is an injection of monoclonal antibodies that is approved for arthritis-related pain in dogs. Its label lists mostly mild side effects, such as urinary tract and skin infections.
Ms. Harris may give remarks about border issues during the visit, according to the people, who insisted on anonymity to discuss a trip that has not yet been made public. The people said final details about exactly where Ms. Harris would visit or what else she might do on the trip have not been decided. The Harris campaign did not immediately provide a comment.
“What he said or didn’t say is between him and the people of North Carolina,” said Mr. Vance, former President Donald J. Trump’s running mate. He added: “I’ve seen some of the statements. I haven’t seen them all. Some of them are pretty gross, to put it mildly. Mark Robinson says that those statements are false, that he didn’t actually speak them. So I think it’s up to Mark Robinson to make his case to the people of North Carolina that those weren’t his statements.”
But since the drug became widely available, some pet owners have reported that their dogs became seriously ill, lost the ability to walk or stand or even died shortly after receiving the drug.
The F.D.A.’s analysis, which is based on more than 3,600 adverse-event reports submitted to the agency and the drug manufacturer, does not prove that Librela caused these problems or estimate how frequently they might occur.
But such reviews can help regulators identify potential side effects that smaller clinical trials may have missed. The F.D.A. has alerted veterinarians to the adverse events that may be associated with Librela and recommended that the drug’s label be updated to include them.
Zoetis, the company that makes Librela, said that more than 21 million doses of the drug had been distributed globally and that side effects were rare. “We at Zoetis — and I personally — stand 100 percent behind Librela as safe and effective,” said Dr. Richard Goldstein, the company’s chief medical officer.
We are having trouble retrieving the article content.
Please enable JavaScript in your browser settings.
tmtplay888Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.
Thank you for your patience while we verify access.
Already a subscriber? Log in.
Want all of The Times? Subscribe.swerte gaming